Order Article Reprints

Settelmeier S, Varasteh Z, Staniszewska M, Beerlage A-L, Zarrad F, Fendler WP, Rischpler C, Notni J, Totzeck M, Herrmann K, et al. Demonstration of the Early Cardiac Bioavailability of a Non-Specific Cell-Targeted Peptide Using Radionuclide-Based Imaging In Vivo. Pharmaceuticals. 2023; 16(6):824. https://doi.org/10.3390/ph16060824

Settelmeier, Stephan, Zohreh Varasteh, Magdalena Staniszewska, Anna-Lena Beerlage, Fadi Zarrad, Wolfgang P. Fendler, Christoph Rischpler, Johannes Notni, Matthias Totzeck, Ken Herrmann, and et al. 2023. "Demonstration of the Early Cardiac Bioavailability of a Non-Specific Cell-Targeted Peptide Using Radionuclide-Based Imaging In Vivo" Pharmaceuticals 16, no. 6: 824. https://doi.org/10.3390/ph16060824

Settelmeier, S., Varasteh, Z., Staniszewska, M., Beerlage, A.-L., Zarrad, F., Fendler, W. P., Rischpler, C., Notni, J., Totzeck, M., Herrmann, K., Rassaf, T., & Hendgen-Cotta, U. B. (2023). Demonstration of the Early Cardiac Bioavailability of a Non-Specific Cell-Targeted Peptide Using Radionuclide-Based Imaging In Vivo. Pharmaceuticals, 16(6), 824. https://doi.org/10.3390/ph16060824